Cite
HARVARD Citation
Wainberg, Z. et al. (n.d.). P-234Phase 1b open-label study evaluating the safety, pharmacokinetics, and preliminary efficacy of ABT-165 plus FOLFIRI in patients with second-line (2L) colorectal cancer (CRC). Annals of oncology. p. . [Online].